Sun BioPharma's Debt - II Round

Sun BioPharma raised a round of funding on February 04, 2014.

Sun BioPharma is a drug development company committed to providing cancer patients with rapid access to therapeutics. SUN-101 is a polyamine analogue which accumulates in the exocrine cells of the pan…

Articles about Sun BioPharma's Debt - II Round: